J.Conor O’Shea

1.3k total citations
40 papers, 934 citations indexed

About

J.Conor O’Shea is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, J.Conor O’Shea has authored 40 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 5 papers in Economics and Econometrics. Recurrent topics in J.Conor O’Shea's work include Acute Myocardial Infarction Research (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers) and Coronary Interventions and Diagnostics (18 papers). J.Conor O’Shea is often cited by papers focused on Acute Myocardial Infarction Research (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers) and Coronary Interventions and Diagnostics (18 papers). J.Conor O’Shea collaborates with scholars based in United States, Canada and United Kingdom. J.Conor O’Shea's co-authors include James E. Tcheng, Michael M. Kitt, Todd J. Lorenz, Sally Greenberg, Gail E. Hafley, Robert M. Califf, Vic Hasselblad, John Strony, Kathryn Williams and Neal S. Kleiman and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

J.Conor O’Shea

40 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.Conor O’Shea United States 15 748 446 162 111 65 40 934
M.L. Knudtson Canada 11 520 0.7× 225 0.5× 115 0.7× 133 1.2× 95 1.5× 20 704
Robert M. Califf United States 13 646 0.9× 373 0.8× 65 0.4× 259 2.3× 39 0.6× 17 997
Lynn B. Oertel United States 8 980 1.3× 130 0.3× 312 1.9× 125 1.1× 59 0.9× 11 1.1k
Margaret Flatley United States 11 442 0.6× 203 0.5× 135 0.8× 126 1.1× 74 1.1× 16 667
Philip Lewis United Kingdom 15 426 0.6× 138 0.3× 38 0.2× 194 1.7× 53 0.8× 60 938
G Hanania France 13 823 1.1× 308 0.7× 78 0.5× 125 1.1× 48 0.7× 42 955
Luke Bamber United States 14 849 1.1× 187 0.4× 655 4.0× 25 0.2× 144 2.2× 27 1.1k
Zorana Vasiljević Serbia 12 476 0.6× 134 0.3× 26 0.2× 112 1.0× 37 0.6× 34 638
Ann Quill United States 8 910 1.2× 339 0.8× 81 0.5× 306 2.8× 80 1.2× 9 1.1k
Dmitry Abramov United States 15 416 0.6× 189 0.4× 17 0.1× 49 0.4× 30 0.5× 110 736

Countries citing papers authored by J.Conor O’Shea

Since Specialization
Citations

This map shows the geographic impact of J.Conor O’Shea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.Conor O’Shea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.Conor O’Shea more than expected).

Fields of papers citing papers by J.Conor O’Shea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.Conor O’Shea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.Conor O’Shea. The network helps show where J.Conor O’Shea may publish in the future.

Co-authorship network of co-authors of J.Conor O’Shea

This figure shows the co-authorship network connecting the top 25 collaborators of J.Conor O’Shea. A scholar is included among the top collaborators of J.Conor O’Shea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.Conor O’Shea. J.Conor O’Shea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yusuf, Ali, Timothy Barry, J.Conor O’Shea, et al.. (2023). Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis. Cardio-Oncology. 9(1). 34–34. 10 indexed citations
2.
Mehta, Rajendra H., J.Conor O’Shea, Amanda Stebbins, et al.. (2011). Association of Mortality With Years of Education in Patients With ST-Segment Elevation Myocardial Infarction Treated With Fibrinolysis. Journal of the American College of Cardiology. 57(2). 138–146. 33 indexed citations
3.
4.
Déry, Jean‐Pierre, Mark Campbell, Karen S. Pieper, et al.. (2007). Complementary effects of thienopyridine pretreatment and platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention; Results from the ESPRIT trial. Catheterization and Cardiovascular Interventions. 70(1). 44–51. 10 indexed citations
5.
Puma, Joseph, et al.. (2006). Clinical Characteristics Predict Benefits From Eptifibatide Therapy During Coronary Stenting. Journal of the American College of Cardiology. 47(4). 715–718. 13 indexed citations
6.
Rebeiz, Abdallah, Jean‐Pierre Déry, Anastasios A. Tsiatis, et al.. (2004). Optimal duration of eptifibatide infusion in percutaneous coronary intervention (An ESPRIT substudy). The American Journal of Cardiology. 94(7). 926–929. 10 indexed citations
7.
Cantor, Warren J., James E. Tcheng, James C. Blankenship, et al.. (2004). Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience.. PubMed. 16(9). 475–81. 2 indexed citations
8.
Tolleson, Thaddeus R., J.Conor O’Shea, John A. Bittl, et al.. (2003). Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention. Journal of the American College of Cardiology. 41(3). 386–393. 74 indexed citations
9.
O’Shea, J.Conor, Robert G. Wilcox, Allan M. Skene, et al.. (2002). Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone. The American Journal of Cardiology. 90(12). 1374–1377. 28 indexed citations
10.
11.
Tcheng, James E., J.Conor O’Shea, Bonnie H. Weiner, et al.. (2002). Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Journal of the American College of Cardiology. 40(6). 1085–1091. 42 indexed citations
12.
Kandzari, David E., J.Conor O’Shea, Benjamin H. Trichon, et al.. (2002). Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001. American Heart Journal. 143(2). 217–228. 8 indexed citations
13.
14.
O’Shea, J.Conor, et al.. (2002). In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). The American Journal of Cardiology. 89(1). 61–64. 14 indexed citations
15.
Shibata, Marcelo C., Marcus Flather, Diego Pérez de Arenaza, Duolao Wang, & J.Conor O’Shea. (2001). Potential impact of socioeconomic differences on clinical outcomes in international clinical trials. American Heart Journal. 141(6). 1019–1024. 13 indexed citations
16.
O’Shea, J.Conor, Gail E. Hafley, Sally Greenberg, et al.. (2001). Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention. JAMA. 285(19). 2468–2468. 160 indexed citations
17.
Blankenship, James C., Gudaye Tasissa, J.Conor O’Shea, et al.. (2001). Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. Journal of the American College of Cardiology. 38(3). 653–658. 43 indexed citations
18.
McGuire, Darren K., et al.. (2000). Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000. American Heart Journal. 140(1). 181–188. 3 indexed citations
19.
O’Shea, J.Conor. (1997). Factors confounding assessment of ambulatory blood pressure monitors, studied during formal evaluation of the tycos Quiet-Trak. American Journal of Hypertension. 10(2). 175–180. 14 indexed citations
20.
O’Shea, J.Conor, et al.. (1996). Cardiovascular Effects of Cocaine in Neonates Exposed Prenatally. American Journal of Perinatology. 13(1). 1–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.L. Knudtson Breakdown of academic impact, for papers by Robert M. Califf Breakdown of academic impact, for papers by Lynn B. Oertel Breakdown of academic impact, for papers by Margaret Flatley Breakdown of academic impact, for papers by Philip Lewis Breakdown of academic impact, for papers by G Hanania Breakdown of academic impact, for papers by Luke Bamber Breakdown of academic impact, for papers by Zorana Vasiljević Breakdown of academic impact, for papers by Ann Quill Breakdown of academic impact, for papers by Dmitry Abramov
Rankless by CCL
2026